Efficacy News and Research

RSS
CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

CIRM awards Salk Institute $10.8M grant to develop stem-cell based therapy for Lou Gehrig's Disease

Cardiome Pharmam, Astellas Pharma begin patient enrolment for ACT 5 trial

Cardiome Pharmam, Astellas Pharma begin patient enrolment for ACT 5 trial

Repros Therapeutics amends its existing license for Proellex

Repros Therapeutics amends its existing license for Proellex

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

CNS Response to present results from depression efficacy study at U.S. Psychiatric and Mental Health Congress

NIH awards contract to LRRI for anthrax research

NIH awards contract to LRRI for anthrax research

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Quinnova Pharmaceuticals raises $17.4 million through Series B financing

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

Helix BioMedix' SmartPeptides technology products demonstrate improvement in skin texture

FDA approves the 100th antiretroviral drug in association with PEPFAR

FDA approves the 100th antiretroviral drug in association with PEPFAR

DSM Biomedical announces new non-biofouling coating technology for medical applications

DSM Biomedical announces new non-biofouling coating technology for medical applications

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

First spinal surgery in the U.S. using Osteotech's MagniFuse PC bone graft technology performed

First spinal surgery in the U.S. using Osteotech's MagniFuse PC bone graft technology performed

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

Deloitte releases "Acquisitions versus Product Development: An Emerging Trend in Life Sciences" report

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

Study of ‘real-life’ experiences of patients undergoing 5-ASA treatment for ulcerative colitis

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Treatment with TYSABRI reduces the rate of hospitalization in Crohn’s patients

Development of VLN cigarettes for use in smoking cessation continues: 22nd Century

Development of VLN cigarettes for use in smoking cessation continues: 22nd Century

RadMD offers tips for efficient use of medical imaging during clinical trial process

RadMD offers tips for efficient use of medical imaging during clinical trial process

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study

Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study

Nabriva Therapeutics closes EUR 15 million financing

Nabriva Therapeutics closes EUR 15 million financing

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.